Pharmacogenomics in the treatment of narcolepsy. - Wikidata - awgldk - TriplyDB

Pharmacogenomics in the treatment of narcolepsy.

Pharmacogenomics in the treatment of narcolepsy.

http://www.wikidata.org/entity/Q35040879

about

Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested.Genes for normal sleep and sleep disorders.Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

P2860

Q33360439-8E4021A0-8D7B-49F1-A5C8-C126C1AD4F0D Q34474283-5BCDA4F9-FE94-4F52-B658-20BDB914CCC9 Q36401912-F75FCB2D-9445-4973-83EF-9E8583105F7B

P2860

Pharmacogenomics in the treatment of narcolepsy.

http://www.wikidata.org/entity/Q35040879

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pharmacogenomics in the treatment of narcolepsy.

@ast

Pharmacogenomics in the treatment of narcolepsy.

@en

type

label

Pharmacogenomics in the treatment of narcolepsy.

@ast

Pharmacogenomics in the treatment of narcolepsy.

@en

prefLabel

Pharmacogenomics in the treatment of narcolepsy.

@ast

Pharmacogenomics in the treatment of narcolepsy.

@en

P1433

Q35040879-31EC39C1-FD0C-4FAD-98A0-3E653FCE735E

P1476

Q35040879-D7B9BD6F-E2D6-4428-8538-B1CD8CB527B8

P2093

Q35040879-60A9E836-40B6-45ED-AFC8-44F17ADFC026

P2860

Q35040879-00D0456B-52A5-42B4-B874-1C443531A974

Q35040879-0F32533B-54CD-4628-B16E-4B970866B2EF

Q35040879-14665246-1DD0-4EE6-995F-C91015574D27

Q35040879-15A6AE57-45BF-44AF-AFF2-D78F23420849

Q35040879-15BBA337-57E5-4898-90E5-2395609475F1

Q35040879-17412166-9358-4D74-B3B9-8F9B30357AAE

Q35040879-21FD049A-921B-456C-AFFF-7B7CED106C86

Q35040879-29B5FA5E-3AFC-4FFC-B547-DF80826D8264

Q35040879-29F4A587-8931-467C-AEB8-CC7EE4DFBC5C

Q35040879-2BB7B93B-24ED-4789-B114-DF8F07ABDDA7

P304

Q35040879-45A82E28-9FF1-460A-97F5-730DBC801179

P31

Q35040879-180FF54A-A48B-40FD-BAE3-A827E4E9189C

P356

Q35040879-12348E86-5E99-490A-8B7F-4BE241F21387

P433

Q35040879-4A850106-654E-4802-826A-A56D89152E8B

P478

Q35040879-F21F1BC1-016C-4264-BAFE-BA51262AD5F5

P50

Q35040879-0900BA0C-675E-4F2A-A007-C5D69491F597

P577

Q35040879-00A7DA20-18E7-4935-ACAE-D8956F408432

P698

Q35040879-D0659BE5-35A5-49CB-8D18-014819CFD92A

P921

Q35040879-0390F9B6-B5BB-40AD-9375-0AF632E757E2

Q35040879-CB55908D-73CD-4D68-B2E2-7DD024ED9111

P356

PHGS.4.1.23.22590

P1433

Pharmacogenomics

P1476

Pharmacogenomics in the treatment of narcolepsy.

@en

P2093

Yves Dauvilliers

http://www.w3.org/2001/XMLSchema#string

P2860

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

Reduced number of hypocretin neurons in human narcolepsy.

Pharmacogenetics and psychopharmacotherapy.

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine

Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment

P304

23-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/PHGS.4.1.23.22590

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12517283

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics